Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.83 |
| ▸ | PPARA | Q07869 | 3/20 | 0.83 |
| ▸ | PPARG | P37231 | 1/20 | 0.83 |
| ▸ | PPARD | Q03181 | 1/20 | 0.83 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.65 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.65 |
| ▸ | AR | P10275 | 1/20 | 0.65 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.63 |
| ▸ | MAPT | P10636 | 4/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | GAA | P10253 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyleugenol SCHEMBL29376951 | 0.91 | ALDH1A1 (1.00) | ALDH1A1PPARAPPARGPPARDPTGS1 | |
| Methyleugenol SCHEMBL1869396 | 0.91 | ALDH1A1 (1.00) | ALDH1A1PPARAPPARGPPARDPTGS1 | |
| Methyleugenol SCHEMBL113794 | 0.91 | ALDH1A1 (1.00) | ALDH1A1PPARAPPARGPPARDPTGS1 | |
| Methyleugenol SCHEMBL27951383 | 0.89 | ALDH1A1 (0.96) | ALDH1A1PPARAPPARGPPARDPTGS1 | |
| Methyleugenol SCHEMBL27600712 | 0.89 | ALDH1A1 (0.96) | ALDH1A1PPARAPPARGPPARDPTGS1 | |
| Methyleugenol SCHEMBL5564539 | 0.89 | ALDH1A1 (0.96) | ALDH1A1PPARAPPARGPPARDPTGS1 | |
| SCHEMBL1870530 | 0.87 | ALDH1A1 (0.86) | ALDH1A1PPARAPPARGPPARDPTGS1 | |
| Methyleugenol SCHEMBL28067388 | 0.87 | ALDH1A1 (0.93) | ALDH1A1PPARAPPARGPPARDPTGS1 | |
| SCHEMBL4353980 | 0.87 | ALDH1A1 (0.86) | ALDH1A1PPARAPPARGPPARDPTGS1 | |
| SCHEMBL7233407 | 0.84 | ALDH1A1 (0.80) | ALDH1A1PPARAPPARGPPARDPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4059348-A1 | MIXTURE OF A FOLCYSTEINE-BASED BIOSTIMULANT AND AN AGROTOXIC SUBSTANCE OF INTEREST RESULTING IN A QUANTITATIVELY, QUALITATIVELY AND TIME-RELATED RESULT-POTENTIATING ACTION AS OBSERVED IN AN AGRICULTURAL CROP OF A PLANT OF INTEREST | UPL Corporation Limited (MU) | 2022-09-21 | — | — | EP | claimed |
| US-20220279784-A1 | Mixture of a Folcysteine-Based Biostimulant and an Agrotoxic Substance of Interest Resulting in a Quantitatively, Qualitatively and Time-Related Result-potentiating Action as Observed in an Agricultural Crop of a Plant of Interest | UPL Corporation Limited (MU) | 2022-09-08 | — | — | US | claimed |
| US-20200337305-A1 | Mixture of a Folcysteine-based Biostimulant and an Agrotoxic Substance of Interest Resulting in a Quantitatively, Qualitatively and Time-related Result-potentiating Action as Observed in an Agricultural Crop of a Plant of Interest | UPL Corporation Limited (MU) | 2020-10-29 | — | — | US | claimed |
| EP-3679796-A1 | MIXTURE OF A FOLCYSTEINE-BASED BIOSTIMULANT AND AN AGROTOXIC SUBSTANCE OF INTEREST RESULTING IN A QUANTITATIVELY, QUALITATIVELY AND TIME-RELATED RESULT-POTENTIATING ACTION AS OBSERVED IN AN AGRICULTURAL CROP OF A PLANT OF INTEREST | UPL Corporation Limited (MU) | 2020-07-15 | — | — | EP | claimed |
| EP-4059348-A1 | MIXTURE OF A FOLCYSTEINE-BASED BIOSTIMULANT AND AN AGROTOXIC SUBSTANCE OF INTEREST RESULTING IN A QUANTITATIVELY, QUALITATIVELY AND TIME-RELATED RESULT-POTENTIATING ACTION AS OBSERVED IN AN AGRICULTURAL CROP OF A PLANT OF INTEREST | UPL Corporation Limited (MU) | 2022-09-21 | — | — | EP | disclosed |
| US-20220279784-A1 | Mixture of a Folcysteine-Based Biostimulant and an Agrotoxic Substance of Interest Resulting in a Quantitatively, Qualitatively and Time-Related Result-potentiating Action as Observed in an Agricultural Crop of a Plant of Interest | UPL Corporation Limited (MU) | 2022-09-08 | — | — | US | disclosed |
| US-11388900-B2 | Mixture of a folcysteine-based biostimulant and an agrotoxic substance of interest resulting in a quantitatively, qualitatively and time-related result-potentiating action as observed in an agricultural crop of a plant of interest | UPL Corporation Limited (MU) | 2022-07-19 | — | — | US | disclosed |
| US-20200337305-A1 | Mixture of a Folcysteine-based Biostimulant and an Agrotoxic Substance of Interest Resulting in a Quantitatively, Qualitatively and Time-related Result-potentiating Action as Observed in an Agricultural Crop of a Plant of Interest | UPL Corporation Limited (MU) | 2020-10-29 | — | — | US | disclosed |
| EP-3679796-A1 | MIXTURE OF A FOLCYSTEINE-BASED BIOSTIMULANT AND AN AGROTOXIC SUBSTANCE OF INTEREST RESULTING IN A QUANTITATIVELY, QUALITATIVELY AND TIME-RELATED RESULT-POTENTIATING ACTION AS OBSERVED IN AN AGRICULTURAL CROP OF A PLANT OF INTEREST | UPL Corporation Limited (MU) | 2020-07-15 | — | — | EP | disclosed |
| US-8163753-B2 | 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| EP-1678185-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMA CO LTD (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| EP-1678185-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005042542-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | NR2C2, NR0B2, NR4A2 | ALDH1A1 412/4885PPARA 337/4885PPARG 457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.